LEADER 05648nam 22006975 450 001 9910300187003321 005 20200705102438.0 010 $a3-642-37099-3 024 7 $a10.1007/978-3-642-37099-1 035 $a(CKB)3710000000291441 035 $a(EBL)1966008 035 $a(OCoLC)896345263 035 $a(SSID)ssj0001386735 035 $a(PQKBManifestationID)11752542 035 $a(PQKBTitleCode)TC0001386735 035 $a(PQKBWorkID)11394346 035 $a(PQKB)10221683 035 $a(DE-He213)978-3-642-37099-1 035 $a(MiAaPQ)EBC1966008 035 $a(PPN)183095626 035 $a(EXLCZ)993710000000291441 100 $a20141118d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aRadiotherapy in Prostate Cancer $eInnovative Techniques and Current Controversies /$fedited by Hans Geinitz, Mack Roach III, Nicholas van As 205 $a1st ed. 2015. 210 1$aBerlin, Heidelberg :$cSpringer Berlin Heidelberg :$cImprint: Springer,$d2015. 215 $a1 online resource (288 p.) 225 1 $aRadiation Oncology 300 $aDescription based upon print version of record. 311 $a3-642-37098-5 320 $aIncludes bibliographical references. 327 $aImaging, delineation and immobilization: MRI and MR-spectroscopy -- PET imaging in prostate cancer -- Phase contrast X-ray imaging- next generation CT imaging -- Organ contouring for IMRT -- General aspects of patient immobilization -- Internal immobilization: From rectal balloon to hyaluronic acid -- Clinical endpoints: Biochemical recurrence? a valuable endpoint? -- Overall and disease-free survival ? too long to wait? -- Late toxicity ? current scoring concepts -- Quality of life: Assessment and Correlates -- Dose escalation and new radiation techniques: Dose escalation ? an update on randomized clinical trials -- IMRT for prostate cancer -- IGRT- how and when -- Tracking in prostate cancer -- Locally advanced disease: Techniques of pelvic lymphatic irradiation -- Prophylactic treatment of the pelvic lymphatics: pro -- Prophylactic treatment of the pelvic lymphatics: contra -- Hormonal therapy and radiation therapy - randomized and prospective trials -- Treatment of clinically involved lymph nodes -- Hypofractionation: Hypofractionation in prostate cancer- biological aspects -- Hypofractionation: Clinical data -- Simultaneous integrated boost techniques -- Brachytherapy: Principals of 3D, highly conformal brachytherapy -- Seed implantation -- HDR brachytherapy -- Adjuvant treatment and salvage treatment: Target volume definition in postoperative radiotherapy -- Randomized trials for adjuvant radiotherapy -- Salvage radiotherapy after radical prostatectomy -- Salvage prostatectomy after radiotherapy -- Use of protons and heavy ions: Proton therapy for prostate cancer: technological and clinical aspects -- There is evidence for the superiority of protons or heavy ions, pro -- There is evidence for the superiority of protons or heavy ions, contra.  . 330 $aRadiation treatment is rapidly evolving owing to the coordinated research of physicists, engineers, computer and imaging specialists, and physicians. Today, the arsenal of ?high-precision? or ?targeted? radiotherapy includes multimodal imaging, in vivo dosimetry, Monte Carlo techniques for dose planning, patient immobilization techniques, intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), biologically adapted radiotherapy (BART), quality assurance methods, novel methods of brachytherapy, and, at the far end of the scale, particle beam radiotherapy using protons and carbon ions. These approaches are like pieces of a puzzle that need to be put together to provide the prostate cancer patient with high-level optimized radiation treatment. This book examines in detail the role of the above-mentioned innovative radiation techniques in the management of prostate cancer. In addition, a variety of current controversies regarding treatment are carefully explored, including whether prophylactic treatment of the pelvic lymphatics is essential, the magnitude of the effect of dose escalation, whether a benefit accrues from hypofractionation, and what evidence exists for the superiority of protons or heavy ions. Radiotherapy in Prostate Cancer: Innovative Techniques and Current Controversies is intended for both radiation oncologists and urologists with an interest in the up-to-date capabilities of modern radiation oncology for the treatment of prostate cancer. 410 0$aRadiation Oncology 606 $aRadiotherapy 606 $aOncology   606 $aUrology 606 $aRadiotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H29056 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aUrology$3https://scigraph.springernature.com/ontologies/product-market-codes/H62002 615 0$aRadiotherapy. 615 0$aOncology  . 615 0$aUrology. 615 14$aRadiotherapy. 615 24$aOncology. 615 24$aUrology. 676 $a616.99463 702 $aGeinitz$b Hans$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aRoach III$b Mack$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $avan As$b Nicholas$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910300187003321 996 $aRadiotherapy in Prostate Cancer$91764148 997 $aUNINA